Rick E. Winningham - 19 Aug 2022 Form 4 Insider Report for Theravance Biopharma, Inc. (TBPH)

Role
CHIEF EXECUTIVE OFFICER, Director
Signature
/s/ Brett A. Grimaud, Attorney-in-Fact
Issuer symbol
TBPH
Transactions as of
19 Aug 2022
Net transactions value
-$147,609
Form type
4
Filing time
23 Aug 2022, 19:03:55 UTC
Previous filing
09 Aug 2022
Next filing
22 Nov 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TBPH Ordinary Shares Tax liability $147,609 -15,804 -1.1% $9.34 1,424,784 19 Aug 2022 Direct F1
holding TBPH Ordinary Shares 92,567 19 Aug 2022 By Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction.